1312779-99-9

Upstream product

• 1232059-52-7 ethyl 6-chloro-5-methyl-pyrimidine-4-carboxylate 
• 1312590-38-7 C₁₃H₁₉NO 
• 1159010-94-2 6-hydroxy-5-methyl-pyrimidine-4-carboxylic acid 
• 4294-57-9 para-methylphenylmagnesium bromide 
• 5205-39-0 ethyl glutaroyl chloride 
• 42482-94-0 ethyl 5-(4-methylphenyl)-5-oxopentanoate 
• 833-85-2 5-(4-methylphenyl)-5-oxopentanoic acid 
• 1017209-81-2 C₁₂H₁₆O₃ 
• 1312589-93-7 C₁₄H₁₈O₃ 
• 1312589-98-2 C₁₃H₁₅NO 

Downstream Products

• 1312780-00-9 C₁₉H₂₃N₃O₃ 

Relevant academic research and scientific papers

NEW SELECTIVE CCR2 ANTAGONISTS

The present invention relates to novel and selective antagonists for CCR2 (CC chemokine receptor 2) and their use for providing medicaments for treating conditions and diseases, especially pulmonary diseases like asthma and COPD as well as pain.

NEW CCR2 RECEPTOR ANTAGONISTS AND USES THEREOF

The present invention relates to novel antagonists for CCR2 (CC chemokine receptor 2) and their use for providing medicaments for treating conditions and diseases, especially pulmonary diseases like asthma and COPD.

NEW SELECTIVE CCR2 ANTAGONISTS

The present invention relates to novel and selective antagonists for CCR2 (CC chemokine receptor 2) and their use for providing medicaments for treating conditions and diseases, especially pulmonary diseases like asthma and COPD as well as pain.

NEW CCR2 RECEPTOR ANTAGONISTS AND USES THEREOF

The present invention relates to novel antagonists for CCR2 (CC chemokine receptor 2) of Formula (I) and their use for providing medicaments for treating conditions and diseases, especially pulmonary diseases like asthma and COPD.